270 related articles for article (PubMed ID: 13298391)
1. [Some recent developments on the pharmacology of ergot of rye].
ROTHLIN E; FANCHAMPS A
Rev Pathol Gen Physiol Clin; 1955 Dec; 55(673):1427-43. PubMed ID: 13298391
[No Abstract] [Full Text] [Related]
2. [Hypothermic neuroplegia, called artificial hibernation, with dihydrogenated derivatives of ergot of rye; physiological study].
CAHN J; MELON JM; DUBRASQUET ; BODIOU
Anesth Anal; 1954 Oct; 11(3):513-32. PubMed ID: 15444698
[No Abstract] [Full Text] [Related]
3. [PRIMARY DYSMENORRHEA. TRIAL TREATMENT WITH A DERIVATIVE OF RYE ERGOT].
CHABRIER J; BARRIER J
Rev Fr Gynecol Obstet; 1964; 59():345-53. PubMed ID: 14169676
[No Abstract] [Full Text] [Related]
4. [Poisoning by the ergot of rye. (One of its alkaloids: ergonovine)].
SASTRE MACEDO M; ORTEGA CL; HEPNER M
Dia Med; 1960 May; 32():861. PubMed ID: 14441885
[No Abstract] [Full Text] [Related]
5. [Recent chemical research on the alkaloids of ergot of rye].
STOLL A
Farmaco Sci Tec; 1951; 6(4):475-94. PubMed ID: 14872881
[No Abstract] [Full Text] [Related]
6. [On the content of alkaloids in domestic wild rye ergot].
TROPP MIa; SINILOVA NG
Med Prom SSSR; 1961 Aug; 8():10-4. PubMed ID: 14039807
[No Abstract] [Full Text] [Related]
7. [Ergot cultivation on tetraploid rye].
DEUFEL J
Arch Pharm Ber Dtsch Pharm Ges; 1954; 287(6):329-32. PubMed ID: 13198207
[No Abstract] [Full Text] [Related]
8. EFFECT OF THE ERGOT INHIBITOR (CLAVICEPS PURPUREA L.) ON THE TOBACCO MOSAIC VIRUS (TMV).
GUBANSKI M; LOWKIS L
Acta Microbiol Pol (1952); 1964; 13():169-75. PubMed ID: 14211335
[No Abstract] [Full Text] [Related]
9. [ON THE BIOSYNTHESIS OF PEPTIDE ALKALOIDS FROM CLAVICEPS PURPUREA TUL].
VOIGT R; BORNSCHEIN M
Pharmazie; 1964 Dec; 19():772-5. PubMed ID: 14339166
[No Abstract] [Full Text] [Related]
10. The history and present-day use of ergot.
MOIR JC
Can Med Assoc J; 1955 May; 72(10):727-34. PubMed ID: 14364431
[No Abstract] [Full Text] [Related]
11. A NEW ERGOT ALKALOID FROM MEXICAN MAIZE ERGOT.
AGURELL S; RAMSTAD E
Acta Pharm Suec; 1965 Jun; 2():231-8. PubMed ID: 14326398
[No Abstract] [Full Text] [Related]
12. Artificial inoculation of rye with ergot; a susceptible rye and the control of ergot beetles.
LEWIS RW
J Am Pharm Assoc Am Pharm Assoc; 1948 Dec; 37(12):511-3. PubMed ID: 18122597
[No Abstract] [Full Text] [Related]
13. Chemical and pharmacological studies on the in-vitro cultured ergot. I.
Ogiu K; Shimamoto K
Jpn J Pharmacol; 1952 Sep; 1(1):35-43. PubMed ID: 14945926
[No Abstract] [Full Text] [Related]
14. [Stabilization of the ergot fluid extract Ph. H. V].
SIEGFRIED B; SCHNEIDER R
Pharm Acta Helv; 1953 Jun; 28(6):169-77. PubMed ID: 13100000
[No Abstract] [Full Text] [Related]
15. [Experimental and clinical studies of the dihydrogenated alkaloids of ergot of rye].
SCHNEIDER PB
Schweiz Arch Neurol Psychiatr; 1950; 65(1-2):283-310. PubMed ID: 15430992
[No Abstract] [Full Text] [Related]
16. [Some psychopharmacological effects of hydrogenated extracts of ergot].
MACHADO MR
Sem Med; 1960 Oct; 117():1128-9. PubMed ID: 13764823
[No Abstract] [Full Text] [Related]
17. [ERGOT FROM WILD-GROWING GRASSES AND HYBRID PLANTS AS A POSSIBLE MATERIAL FOR SELECTION OF STRAINS OF CLAVICEPS PURPURAE TUL].
OSTROVSKII NI; BANKOVSKAIA AN
Med Prom SSSR; 1964 Sep; 18():46-8. PubMed ID: 14259576
[No Abstract] [Full Text] [Related]
18. [Treatment of peripheral circulatory disorders with hydrogenated alkaloids of ergot of rye].
ZOZAYA RG
Presse Med (1893); 1956 Jun; 64(47):1086-7. PubMed ID: 13350074
[No Abstract] [Full Text] [Related]
19. The pharmacognosy of smooth brome ergot.
JONES DD; TYLER VE
J Am Pharm Assoc Am Pharm Assoc; 1955 Aug; 44(8):480-3. PubMed ID: 13242443
[No Abstract] [Full Text] [Related]
20. [Treatment of maniacal syndromes by dihydrogenated alkaloids of ergot of rye (hydergine) associated with electroshock].
POSTEL J; COSSA P; BERNUY M
Ann Med Psychol (Paris); 1956 Jun; 114(1):75-80. PubMed ID: 13340372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
